Local agencies and individuals with experience around substance use disorders partnered to make Narcan 'as easily accessible ...
The close of 2024 brought some welcome news about efforts to combat the opioid crisis that’s had devastating effect in the region and across the state for well over 10 ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...
For a second year in a row, Currax delivered greater than 50% year-over-year revenue growth for CONTRAVE®/MYSIMBA® in 2024.